Clinical Edge Journal Scan Commentary: Atopic Dermatitis September 2021August 25, 2021Atopic Dermatitis
Atopic dermatitis: Inadequate disease control and QoL impairments among patients receiving topical therapyAugust 25, 2021Atopic Dermatitis
Abrocitinib emerges as a potential treatment option for moderate-to-severe atopic dermatitisAugust 25, 2021Atopic Dermatitis
Comorbidities account for higher incidence of hospitalization in patients with ADAugust 25, 2021Atopic Dermatitis
Methylation on golli-MBP locus serves as an indicator of atopic dermatitis severity in childrenAugust 25, 2021Atopic Dermatitis
Sleep disturbance and geriatric age in atopic dermatitis: Is there a link?August 25, 2021Atopic Dermatitis
Cold atmospheric plasma alleviates AD severity without any safety issuesAugust 25, 2021Atopic Dermatitis
Difamilast ointment shows promise for pediatric atopic dermatitis in phase 3August 25, 2021Atopic Dermatitis
Upadacitinib shows superior efficacy over dupilumab for moderate-to-severe atopic dermatitis in phase 3bAugust 25, 2021Atopic Dermatitis
Dermatology NewsBimekizumab approved in Europe for psoriasis treatmentAugust 25, 2021PsoriasisPsoriatic Arthritis
